| Abpro Signs US$1.75 B Collaboration Deal with Celltrion |
Abstract
pdf
html
|
|
Amit Kaushik |
|
| Bayer’s Vividion Signs US$930 M Cancer Collaboration with Tavros Therapeutics |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Gilead Signs US$1.7 B Deal with MacroGenics for Bispecific Antibodies |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Surrozen Collaborates with Boehringer Ingelheim to Develop SZN-413 for Retinal Disease |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Sanofi Collaborates with Scribe Therapeutics in CRISPR Cell Therapy Deal |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Puma Biotechnology Enters into Licensing Agreement with Takeda for Alisertib |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Seagen Signs Collaboration and License Agreement with Zai Lab for Tivdak® |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Seagen Enters into License Agreement with Lava Therapeutics for LAVA-1223 |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Bristol Myers Squibb Signs Protein Degradation and Cell Therapy Technology Deals |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Jazz Pharmaceuticals Enters into License Agreement with Zymeworks for Zanidatamab |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| AstraZeneca to Acquire LogicBio for US$68.2 M |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Incyte to Acquire Villaris Therapeutics for US$1.43 B |
Abstract
pdf
html
|
|
Amit Kaushik |
|
| IQVIA Pharma Deals Half-Year Review of 2022 |
Abstract
pdf
|
|
Heather Cartwright, Taskin Ahmed & Lucy Haggerty |
|
